INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Optimizing The Rater Journey

  For scalable CNS trials, central rating models, where a select group of expert raters conduct remote assessments, offer a way to standardize data collection globally while enhancing patient accessibility and inclusion.

• Before You Invest: A Clinical Trial Payment Technology Checklist

  Outdated payment workflows create delays, financial blind spots, and administrative strain in clinical trials. Evaluating integrated, real-time solutions helps reduce burden, improve visibility, and support more efficient, scalable trial execution.

• The Digital Teammate: How AI Is Changing Clinical Research

  AI in clinical research serves as a "digital colleague," enhancing workflows, accelerating data analysis, and empowering study teams with precision, and insightful solutions for better patient outcomes.

• Helping To Power The WHO Solidarity Trial Against COVID-19

  To overcome the unprecedented challenges of large-scale global clinical trials, adopting data capture solutions is essential for ensuring the success of critical research initiatives.

• eConsent For Clinical Trials: Frequently Asked Questions (FAQ)

  8/5/2026

  Got questions about eConsent? Here we break down how digital consent works, why it beats paper, and how it helps sites, sponsors, and participants across the trial lifecycle.

• Expedite Drug Development With An Integrated CDMO-CRO Model

  2/6/2026

  From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.

• Scaling Global Vaccine Mega-Trials For A Top Five Pharma

  4/16/2026

  See how high-volume enrollment, dynamic safety data capture, and rapid iteration can support global studies operating under intense timelines and scale.

• Modern Post-Market Trials Driven By RWD – Is Your EDC Ready?

  7/7/2025

  Explore the transformative role of real-world data (RWD) and advanced Electronic Data Capture (EDC) systems in post-market research, marking a departure from traditional Phase IV trials.

• Reimagine Quality: Responding To EOL Deadlines

  10/14/2026

  Delay, migrate, or reimagine? Learn how rethinking quality operations around AI can triple team productivity and keep you inspection-ready for the next decade.